Synthesis and biological activity of vicinal diaryl-substituted 1H-imidazoles

被引:258
作者
Bellina, Fabio [1 ]
Cauteruccio, Silvia [1 ]
Rossi, Renzo [1 ]
机构
[1] Univ Pisa, Dipartimento Chim & Chim Ind, I-56126 Pisa, Italy
关键词
imidazoles; synthesis; selectivity; bioactivity; enzyme inhibitors;
D O I
10.1016/j.tet.2007.02.075
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
The procedures utilized for the synthesis of vicinal diaryl-substituted 1H-imidazoles, and the biological properties of these compounds are discussed. Several interesting procedures for the synthesis of 1,2-diaryl-1H-imidazoles involve the elaboration of imidazole derivatives instead of the construction of the heteroaromatic ring. The synthesis strategy of 1,5-diaryl-1H-imidazoles, was employed to prepare a large variety of pharmacologically interesting compounds that include COX-2-selective inhibitors. The mitogen-activated protein (MAP) kinases are able to mediate intracellular signal transduction and participate in a number of physiological as well as pathophysiological cellular processes including cell growth, differentiation, and apoptosis. 4,5-Diaryl-1H-imidazoles have been identified as a class of compounds, which include derivatives showing considerable antimicrobial activity against bacteria, yeast, and fungi.
引用
收藏
页码:4571 / 4624
页数:54
相关论文
共 513 条
  • [1] Catalytic arylation reactions by C-H bond activation with aryl tosylates
    Ackermann, L
    Althammer, A
    Born, R
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2006, 45 (16) : 2619 - 2622
  • [2] Adam J, 2002, EXPERT OPIN THER PAT, V12, P1475
  • [3] Pyrimidinylimidazole inhibitors of p38: Cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activity
    Adams, JL
    Boehm, JC
    Gallagher, TF
    Kassis, S
    Webb, EF
    Hall, R
    Sorenson, M
    Garigipati, R
    Griswold, DE
    Lee, JC
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (21) : 2867 - 2870
  • [4] Pyrimidinylimidazole inhibitors of CSBP/P37 kinase demonstrating decreased inhibition of hepatic cytochrome P450 enzymes
    Adams, JL
    Boehm, JC
    Kassis, S
    Gorycki, PD
    Webb, EF
    Hall, R
    Sorenson, M
    Lee, JC
    Ayrton, A
    Griswold, DE
    Gallagher, TF
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (22) : 3111 - 3116
  • [5] ADAMS JL, 1998, 15 INT S MED CHEM ED
  • [6] ALCADE E, 2005, J ORG CHEM, P1637
  • [7] Synthesis and structure -: Activity relationship of a new series of COX-2 selective inhibitors:: 1,5-diarylimidazoles
    Almansa, C
    Alfón, J
    de Arriba, AF
    Cavalcanti, FL
    Escamilla, I
    Gómez, LA
    Miralles, A
    Soliva, R
    Bartrolí, J
    Carceller, E
    Merlos, M
    García-Rafanell, J
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (16) : 3463 - 3475
  • [8] ALMANSA C, 2001, ACS NAT M CHIC IL AU
  • [9] Biochemical, cellular, and pharmacological aspects of the multidrug transporter
    Ambudkar, SV
    Dey, S
    Hrycyna, CA
    Ramachandra, M
    Pastan, I
    Gottesman, MM
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1999, 39 : 361 - 398
  • [10] Origins, current status, and future challenges of green chemistry
    Anastas, PT
    Kirchhoff, MM
    [J]. ACCOUNTS OF CHEMICAL RESEARCH, 2002, 35 (09) : 686 - 694